Clinical Genetics · Pittsburgh, PA
NPI
1811277130
Since 2011
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4401 Penn Ave, Faculty Pavilion
Pittsburgh, PA, 15224
Phone (412) 692-5070
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,358
14 services
Medicare patients, 2024
12
Average age 57
Drug cost, 2024
$2.3M
73 prescriptions
Company payments, 2025
$4,989
From 7 companies
Medicare prescription drug claims, 2024
In 2024, the drug Damara Ortiz prescribed most often to Medicare patients was Fabrazyme (Agalsidase Beta), with 26 prescriptions and refills. In total Damara Ortiz wrote 73 Medicare prescriptions that cost $2.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Fabrazyme Agalsidase Beta | 26 | 26 | Under 11 | $1.0M |
| Galafold Migalastat Hcl | 18 | 27 | Under 11 | $853K |
| Cerdelga Eliglustat Tartrate | 13 | 13 | Under 11 | $412K |
Brand drugs: 62 claims; generic drugs: 11 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Damara Ortiz $4,989 ($4,989 in general payments such as food, travel and fees) from 7 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $2,400.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.